key: cord-0760682-c8pzyz85
authors: Gu, Tian; Mack, Jasmine A.; Salvatore, Maxwell; Prabhu Sankar, Swaraaj; Valley, Thomas S.; Singh, Karandeep; Nallamothu, Brahmajee K.; Kheterpal, Sachin; Lisabeth, Lynda; Fritsche, Lars G.; Mukherjee, Bhramar
title: Characteristics Associated With Racial/Ethnic Disparities in COVID-19 Outcomes in an Academic Health Care System
date: 2020-10-21
journal: JAMA Netw Open
DOI: 10.1001/jamanetworkopen.2020.25197
sha: df0cdf6794c843e8e9e7fd21eeb9bf5fe3ab4971
doc_id: 760682
cord_uid: c8pzyz85

IMPORTANCE: Black patients are overrepresented in the number of COVID-19 infections, hospitalizations, and deaths in the US. Reasons for this disparity may be due to underlying comorbidities or sociodemographic factors that require further exploration. OBJECTIVE: To systematically determine patient characteristics associated with racial/ethnic disparities in COVID-19 outcomes. DESIGN, SETTING, AND PARTICIPANTS: This retrospective cohort study used comparative groups of patients tested or treated for COVID-19 at the University of Michigan from March 10, 2020, to April 22, 2020, with an outcome update through July 28, 2020. A group of randomly selected untested individuals were included for comparison. Examined factors included race/ethnicity, age, smoking, alcohol consumption, comorbidities, body mass index (BMI; calculated as weight in kilograms divided by height in meters squared), and residential-level socioeconomic characteristics. EXPOSURE: In-house polymerase chain reaction (PCR) tests, commercial antibody tests, nasopharynx or oropharynx PCR deployed by the Michigan Department of Health and Human Services and reverse transcription–PCR tests performed in external labs. MAIN OUTCOMES AND MEASURES: The main outcomes were being tested for COVID-19, having test results positive for COVID-19 or being diagnosed with COVID-19, being hospitalized for COVID-19, requiring intensive care unit (ICU) admission for COVID-19, and COVID-19–related mortality (including inpatient and outpatient). Medical comorbidities were defined from the International Classification of Diseases, Ninth Revision, and International Classification of Diseases, Tenth Revision, codes and were aggregated into a comorbidity score. Associations with COVID-19 outcomes were examined using odds ratios (ORs). RESULTS: Of 5698 patients tested for COVID-19 (mean [SD] age, 47.4 [20.9] years; 2167 [38.0%] men; mean [SD] BMI, 30.0 [8.0]), most were non-Hispanic White (3740 patients [65.6%]) or non-Hispanic Black (1058 patients [18.6%]). The comparison group included 7168 individuals who were not tested (mean [SD] age, 43.1 [24.1] years; 3257 [45.4%] men; mean [SD] BMI, 28.5 [7.1]). Among 1139 patients diagnosed with COVID-19, 492 (43.2%) were White and 442 (38.8%) were Black; 523 (45.9%) were hospitalized, 283 (24.7%) were admitted to the ICU, and 88 (7.7%) died. Adjusting for age, sex, socioeconomic status, and comorbidity score, Black patients were more likely to be hospitalized compared with White patients (OR, 1.72 [95% CI, 1.15-2.58]; P = .009). In addition to older age, male sex, and obesity, living in densely populated areas was associated with increased risk of hospitalization (OR, 1.10 [95% CI, 1.01-1.19]; P = .02). In the overall population, higher risk of hospitalization was also observed in patients with preexisting type 2 diabetes (OR, 1.82 [95% CI, 1.25-2.64]; P = .02) and kidney disease (OR, 2.87 [95% CI, 1.87-4.42]; P < .001). Compared with White patients, obesity was associated with higher risk of having test results positive for COVID-19 among Black patients (White: OR, 1.37 [95% CI, 1.01-1.84]; P = .04. Black: OR, 3.11 [95% CI, 1.64-5.90]; P < .001; P for interaction = .02). Having any cancer was associated with higher risk of positive COVID-19 test results for Black patients (OR, 1.82 [95% CI, 1.19-2.78]; P = .005) but not White patients (OR, 1.08 [95% CI, 0.84-1.40]; P = .53; P for interaction = .04). Overall comorbidity burden was associated with higher risk of hospitalization in White patients (OR, 1.30 [95% CI, 1.11-1.53]; P = .001) but not in Black patients (OR, 0.99 [95% CI, 0.83-1.17]; P = .88; P for interaction = .02), as was type 2 diabetes (White: OR, 2.59 [95% CI, 1.49-4.48]; P < .001; Black: OR, 1.17 [95% CI, 0.66-2.06]; P = .59; P for interaction = .046). No statistically significant racial differences were found in ICU admission and mortality based on adjusted analysis. CONCLUSIONS AND RELEVANCE: These findings suggest that preexisting type 2 diabetes or kidney diseases and living in high–population density areas were associated with higher risk for COVID-19 hospitalization. Associations of risk factors with COVID-19 outcomes differed by race.

Abbreviations: MM, Michigan Medicine; ICU, intensive care unit; BMI, body mass index; SES, social economics status; NDI, 2010 Neighborhood Socioeconomic Disadvantage Index. *The population density is used only in the tested positive/susceptibility model as a covariate.

Patients who always tested negative for COVID-19

Not-Hospitalized Patients in the positive COVID cohort who have no inpatient stays after 3/5/2020

Hospitalized Patients in the positive COVID cohort who checked in as an inpatient after 3/5/2020 at least once. ICU Patients in the positive COVID cohort who checked into the ICU during their inpatient stay after 3/5/2020. Deceased

Patients in the cohort who have died based on their Electronic Health Record. Electronic Health Record (EPIC)

Randomly picked cohort of patients who are not part of the COVID-19 cohort (Tested, Positive, Negative), who are alive and who have had an encounter in MM (Inpatient, Outpatient or Emergency) since 2012-04-23. We created an untested comparison group (n=7,168) from the MM database, which is a similar-sized random sample of contemporaneous patients. Specifically, we initially extracted 20,000 individuals before limiting the group to patients who (1) were alive at the time of data pull, (2) have had encounters after 2012-04-22 and (3) who had inpatient, outpatient and/or emergency visits. At the time of the last update for COVID-19 outcomes (July 28, 2020), all patients in the comparison group were alive, and we further excluded 43 patients who were tested after the initial data extraction (April 22, 2020) The model used was: logit P(Y COVID = 1|X, adjustment) = β 0 + β X X + β adjust adjustment j . Here Y COVID is various COVID-19 related outcomes under consideration (i.e., COVID-19 positive, hospitalization and ICU admission); X is the variable/risk factor of interest; and adjustment j , j = 0, …,3 are the four nested covariate adjustment models listed in eTable 1.

Positive (1) Other headache syndromes 541 (11.2) 375 (11.6) 108 (11.8) 94 (9.5) 49 (11.0) 36 (9.4) *n represents the number of patients with available symptom data.

) 2 (5.6%) 211 (17.9%)

Smoking Status Never

Abbreviations: OR, odds ratio; n 0 , sample size for tested patients; n 0 , sample size for comparative group; BMI, body mass index; REF, reference group; SES, social economics status

Neighborhood Socioeconomic Disadvantage Index; adjustment 1, age + sex + race; adjustment 2, adjustment 1 + NDI